BACKGROUND Mucositis is a highly significant, and sometimes dose‐limiting, toxicity of
cancer therapy. The goal of this systematic review was to update the Multinational …

Background Mucositis is a significant toxicity of cancer therapy with numerous systemic
sequelae. The goal of this systematic review was to update the Multinational Association of …

Oral and gastrointestinal mucositis due to cancer therapies such as high-dose
chemotherapy and/or radiation continues to be an important clinical problem. Fortunately …

BACKGROUND Oral and gastrointestinal (GI) mucositis can affect up to 100% of patients
undergoing high‐dose chemotherapy and hematopoietic stem cell transplantation, 80% of …

Mucositis is a common and feared complication of anticancer therapy that can affect up to
90% of certain populations of patients with cancer. Even seemingly uncomplicated …

Purpose The aim of this study was to update the clinical practice guidelines for the use of
basic oral care (BOC) interventions for the prevention and/or treatment of oral mucositis …

Purpose The aim of this systematic review was to update the clinical practice guidelines for
the use of anti-inflammatory agents in the prevention and/or treatment of oral mucositis …

June Eilers, PhD, APRN-CNS, BC, is a research associate professor in the College of
Nursing at the University of Nebraska Medical Center College of Nursing in Omaha; Debra …

Purpose To update the clinical practice guidelines for the use of antimicrobials, mucosal
coating agents, anesthetics, and analgesics for the prevention and/or treatment of oral …

Oral Mucositis (OM) continues to be an oncologic challenge in the context of antineoplastic
therapy for head and neck cancer (HNC) treatment. It is a dose-limiting toxicity of …